Introduction
============

Cholinesterases (ChEs) are serine hydrolases that preferentially act on choline esters. Vertebrates possess two types of cholinesterases (ChEs), corresponding to two distinct genes: acetyl cholinesterase (AChE, EC 3.1.1.7) and butyryl cholinesterase (BChE, EC 3.1.1.8). These two enzymes are distinguished on the basis of the substrate specificities and their sensitivities to selective inhibitors (Mendel and Rudney, [@B43]; Austin and Berry, [@B1]). The primary function of AChE is to efficiently hydrolyze the neurotransmitter acetylcholine (ACh) at cholinergic synapses (Massoulié et al., [@B41]), whereas the physiological function of BChE in vertebrates remains a question of different speculations. Studies of AChE knockout mice suggested that BChE can partially compensate for the absence of AChE in the nervous system (Xie et al., [@B69]; Duysen et al., [@B16]); therefore BChE could hydrolyze acetylcholine functionally. Poisoning by ChE inhibitors, such as insecticides or nerve gas, results in accumulation of ACh, and uncontrolled activation of cholinergic receptors, which causes cholinergic crisis and potentially leads to death (Feyereisen, [@B21]; Bajgar, [@B2]). On the other hand, controlled treatment with ChE inhibitors are used in therapeutics for patients suffering from myasthenia gravis (Brenner et al., [@B8]; Mehndiratta et al., [@B42]), Alzheimer's disease (Giacobini, [@B23]; Stone et al., [@B60]), and Parkinson's disease (Hutchinson and Fazzini, [@B24]; Emre et al., [@B18]).

In vertebrates, *ACHE* gene produces several types of coding sequences differing in an alternative choice of splice acceptor sites in the 3′ region. This process generates different AChE isoforms, named AChE~R~, AChE~H~, and AChE~T~ (Massoulié, [@B39]). They contain the same catalytic domain, but are associated with distinct C-terminal peptides. In contrast, *BCHE* gene produces single type of transcript and generates single type of isoform BChE~T~ (Blong et al., [@B4]). AChE and BChE are well-known for their multiple molecular forms that have their specific localizations: AChE~R~ is a soluble monomer that is up-regulated in the brain under stress stimulation (Kaufer et al., [@B26]; Perrier et al., [@B50]); AChE~H~ is a glycosylphosphatidylinositol-anchored dimer that is mainly expressed in red blood cells (Li et al., [@B35]); AChE~T~ and BChE~T~ are present in collagen-tailed forms at the neuromuscular junction (nmj) and hydrophobic-tailed forms in the brain (Legay et al., [@B33]; Blong et al., [@B4]; Massoulié et al., [@B40]). The molecular forms of AChE~T~ and BChE~T~ in brain and muscle are of particular interest because they are associated with their anchoring proteins: collagen Q (ColQ) or proline-rich membrane anchor (PRiMA). Complexes with ColQ represent the collagen-tailed or asymmetric (A) forms in muscle (Krejci et al., [@B30]), while complexes with PRiMA represent membrane-bound tetrameric globular form (G~4~), mainly in brain (Perrier et al., [@B48], [@B49]; Xie et al., [@B65]) and muscle (Xie et al., [@B66]). In addition, mixed cholinesterases, ColQ-linked AChE--BChE A~12~ hybrid enzyme (Tsim et al., [@B62]) and PRiMA-linked AChE--BChE G~4~ hybrid enzyme (Chen et al., [@B10]) that contain both AChE and BChE homodimers in a single molecule are being found in avian system. Here, we summarized the recent studies on the assembly of oligomeric AChE and BChE, as well as the regulation of AChE and/or BChE biosynthesis in neurons and muscles.

Molecular Forms of AChE and BChE in Brain and Muscle
====================================================

PRiMA-linked globular forms of ChEs
-----------------------------------

In *Xenopus* oocytes, COS-7 cells, neuroblastoma cells, and muscle cells, the expression of PRiMA has been identified as a limiting factor in organizing G~4~ AChE and targeting it to the cell membrane (Perrier et al., [@B48]; Xie et al., [@B66]), as well as in directing its membrane raft localization (Xie et al., [@B67]). In the absence of PRiMA, the G~4~ AChE, or the G~4~ BChE, could not be formed. In the brain, the catalytic subunit contained in G~4~ AChE is AChE~T~ (Inestrosa et al., [@B25]). The expression of PRiMA mRNA and protein are increased with an increment of G~4~ AChE during the development of brain and spinal cord (Leung et al., [@B34]; Xie et al., [@B68]). The PRiMA-linked AChE is also present at the nmj, in which both motor neuron and muscle are the major suppliers. In rat muscles, the protein expression of PRiMA and AChE~T~, as well as the G~4~ AChE, are dramatically increased during development (Leung et al., [@B34]). The parallel expression of PRiMA and G~4~ AChE during the development strengthens the importance of PRiMA in directing, and/or regulating the formation of G~4~ enzyme. The PRiMA-linked G~4~ BChE however has not been well studied, and therefore the expression profile of which in brain or muscle are not fully revealed.

ColQ-linked asymmetric forms of ChEs
------------------------------------

Asymmetric forms of AChE and BChE are characterized by the presence of collagen-like tail, which is formed by the triple helical association of three ColQ subunits (Feng et al., [@B20]). The cDNA encoding ColQ has been cloned in *Torpedo* (Krejci et al., [@B28]), rat (Krejci et al., [@B30]), human (Ohno et al., [@B47]), quail, and chicken (Ruiz and Rotundo, [@B54]). The presence of the collagen-tailed forms of ChEs has been found in all classes of vertebrates, but not in invertebrates. They are specifically expressed in muscles and regulated by physiological activity (Sketelj and Brzin, [@B58]; Deprez et al., [@B14]; Lau et al., [@B31]). In human and rat, *COLQ* gene has two transcripts, ColQ-1 and ColQ-1a: they are differentiatedly expressed in slow-twitch (ColQ-1) and fast-twitch (ColQ-1a) muscles (Ohno et al., [@B47]; Krejci et al., [@B29]). The differentiated expression patterns may account for the synaptic and non-synaptic expression profile of ColQ-linked AChE in fast slow-twitch and fast-twitch muscles, respectively (Lee et al., [@B32]; Crne-Finderle et al., [@B13]; Choi et al., [@B12]).

Existence of AChE--BChE hybrid ChEs
-----------------------------------

Most of our knowledge concerning ChEs derives from the studies on the classical AChE and BChE homogenous oligomers. However, the sequence similarity between AChE~T~ and BChE~T~ has been further emphasized regarding the existence of hybrid A~12~ forms in new-born chicken muscle (Tsim et al., [@B62]), as well as a hybrid G~4~ from in the brain (Chen et al., [@B10]) and embryonic muscles of chicken (Chen et al., [@B11]). In these hybrid enzymes, both AChE~T~ and BChE~T~ are attached to the same anchoring protein, ColQ for A~12~ form and PRiMA for G~4~ form (Figure [1](#F1){ref-type="fig"}). The hybrid enzyme exists as a single type, with equivalent number of AChE and BChE catalytic subunits in a single molecule. Interestingly, the expression of these hybrid molecules in chicken brain and muscle was found to be developmentally regulated. In 1-day-old chicken muscle, the predominant form of AChE is A~12~ hybrid form; however, the proportion of BChE subunits in the hybrid molecules progressively disappear during the muscle development from embryonic, hatching to adult, and the homogeneous asymmetric AChE becomes the sole form upon the muscle maturation (Tsim et al., [@B63]). On the other hand, a continuous increase of AChE--BChE G~4~ hybrid expression was observed in chicken brain, while an obvious decrease was found in the leg muscles. To date, we do not have conclusive idea about the underlining regulatory mechanism of these hybrid enzymes. We believe that AChE--BChE hybrid enzymes could take part in cholinergic functions, which includes (i) they carry the catalytic activities of AChE and BChE in hydrolyzing ACh; (ii) they are associated with the anchoring protein, PRiMA or ColQ, which can anchor the hybrid enzymes onto the plasma membrane in the brain or nmj in the muscles; and (iii) the level of BChE~T~ indirectly regulates the expression of homogenous G~4~ AChE.

![**Two types of AChE--BChE hybrid enzyme. (A)** The PRiMA-linked G~4~ AChE--BChE hybrid in chicken brain. **(B)** The ColQ-linked A~12~ AChE--BChE hybrid in chicken muscle.](fnmol-04-00036-g001){#F1}

In fact, the notion of having the existence of AChE--BChE hybrid enzyme is not new. An abnormal ChE species in the serum of patients suffering from carcinomas was reported (Zakut et al., [@B70]). This abnormal ChE species in human serum was inhibited by both AChE inhibitor BW284c51 and BChE inhibitor iso-OMPA. In addition, a collagen-tailed asymmetric hybrid AChE has been found relatively abundant in young chicken muscle (Tsim et al., [@B63]), but which tends to disappear at the adult stage (Tsim et al., [@B63]). Moreover, a hybrid tetramer having AChE and BChE activity was also found in cyst fluids derived from a human astrocytoma (García-Ayllón et al., [@B22]). However, none of the physiological function of these abnormal ChEs has been elucidated.

Assembly Mechanism of AChE and BChE
===================================

The presence of G~4~ and A~12~ hybrid ChEs raised interesting questions about the organization of the subunits in a hybrid ChE complex. The assembly of AChE and BChE in cells could provide a good model in revealing the protein assembly of oligomers. By using DNA transfected cell cultures, the organization of different subunits in the PRiMA-linked ChE tetramers has been studied (Chen et al., [@B10]). Interestingly, AChE~T~ and BChE~T~ could not form hybrid dimer in the absence of anchoring protein; on the other hand, a single type of hybrid tetramer was clearly observed when the two catalytic subunits were co-expressed with PRiMA. Therefore, a "2 + 2" model is proposed for the organization of the four catalytic subunits in the PRiMA-linked ChE tetramers (Figure [2](#F2){ref-type="fig"}). After protein synthesis, AChE~T~ and BChE~T~ spontaneously form AChE homodimer and BChE~T~ homodimer first. When two dimers (two AChE~T~ dimers, or two BChE~T~ dimers, or one AChE~T~ dimer plus one BChE~T~ dimer) encounter the anchoring protein, PRiMA, and thus ChE tetramers, e.g., G~4~ AChE, G~4~ BChE, and G~4~ AChE/BChE hybrid, are formed.

![**Model for the assembly of PRiMA-linked AChE and BChE tetramers**. When AChE~T~ and BChE~T~ subunits are expressed together, they form their own homodimers spontaneously. PRiMA recruits two homodimers together to form a PRiMA-linked tetramers, e.g., G~4~ AChE, G~4~ BChE. G~4~ hybrid.](fnmol-04-00036-g002){#F2}

T-peptide is necessary for the oligomerization of AChE~T~ and BChE~T~
---------------------------------------------------------------------

AChE~T~ and BChE~T~ have a catalytic domain of approximately 500 amino acids, followed by a C-terminal t-peptide of 40 and 41 residues, respectively. The t-peptide on AChE~T~ and BChE~T~ presents a considerable sequence similarity, with 24 identical residues, including seven aromatic residues and one cysteine near the C-terminus, which are conserved in human, cat, rabbit, mouse, cow, rat, chicken, and *Torpedo* (Massoulié et al., [@B41]).

The t-peptide was reported to play an important role in the biosynthesis of ChEs, particularly in the protein folding and exportation. The presence of aromatic residues in the t-peptide induces the misfolding of newly synthesized AChE~T~ polypeptides, and this effect depends on the hydrophobic character of these residues, because the same effect occurs when they are replaced by leucines (Falasca et al., [@B19]). In the absence of a proline-rich attachment domain (PRAD)-containing anchoring protein, the t-peptide enhanced a pool of AChE~T~ molecules toward endoplasmic reticulum (ER)-associated degradation (Belbeoc'h et al., [@B3]).

The major function of t-peptide is directing the assembly of tetramers of AChE~T~ (Bon and Massoulié, [@B7]) and BChE~T~ (Blong et al., [@B4]), as well as the association with the structure proteins, ColQ and PRiMA (Krejci et al., [@B30]; Perrier et al., [@B48]; Bon et al., [@B6]). The t-peptide is also named as tryptophan (W) amphiphilic tetramerization (WAT) domains, which contains a sector with seven aromatic residues that are strictly conserved between AChE~T~ and BChE~T~. The association between AChE~T~ or BChE~T~ catalytic subunits and anchoring proteins, ColQ and PRiMA, is mostly based on the interaction between four WAT domains on the t-peptides and a PRAD on ColQ or PRiMA (Bon et al., [@B5]; Dvir et al., [@B17]; Noureddine et al., [@B46]). A crystallographic analysis of the complex of synthetic t-peptide and PRAD peptide indicated that four α-helical t-peptides form coiled-coil structure around the PRAD, which is arranged in a poly-proline II helix (Dvir et al., [@B17]). In addition, the formation of disulfide bonds through the cysteine residues near the end of the t-peptides stabilizes the quaternary association, and in fact this association appears to be critical in the case of AChE dimer formation. Dimers could be hardly observed after mutagenesis of the C-terminal cysteine residues in H or T-peptides of *Torpedo* and rat AChE (Morel et al., [@B45]; Chen et al., [@B10]).

The importance of t-peptide in the assembly of AChE~T~ and BChE~T~ was also reported by DNA mutagenesis studies. The truncated mutants, AChE~ΔT~ and BChE~ΔT~, in which the t-peptides were deleted from the catalytic subunits, produced only monomers (Duval et al., [@B15]). AChE~T~ and AChE~BChE-T~, BChE~T~ and BChE~AChE-T~, in which the catalytic domain of each enzyme was swapped with the t-peptide of each other, presented similar assembly ability to form oligomers (Liang et al., [@B36]; Chen et al., [@B10]).

The FHB domain is involved in the selection of catalytic subunits during dimerization
-------------------------------------------------------------------------------------

Although the nature of AChE~T~ and BChE~T~ oligomers depends on the presence of the t-peptides, the catalytic domains also influence the oligomerization patterns. The X-ray crystallography studies of *Torpedo* AChE dimers showed that the contact zone between two AChE~H~ subunits could be a "four-helix bundle" (FHB), formed by two α helices from each catalytic domain (Sussman et al., [@B61]). In addition, rat AChE~T~ was also demonstrated to dimerize through FHB inter-subunit contact zone (Morel et al., [@B45]). Based on these findings, we compared the predicted FHB sequences that are responsible for the dimeric contact zone of AChE~T~ and BChE~T~ from different species. Indeed, FHB domains are highly conserved across different species for either AChE or BChE, including human, mouse, rat, chicken, and *Torpedo* (Figure [3](#F3){ref-type="fig"}). On the other hand, the similarity between FHB domains of AChE~T~ and BChE~T~ is very low. An inter-species hybrid dimer could be formed between human AChE~T~ and chicken AChE~T~, but not between mammalian AChE~T~ and BChE~T~, in transfected HEK293T cells (Chen et al., [@B10]). The selectivity of dimerization seems to be based on the feature that the FHB domains of AChE are highly conserved among different species of vertebrates, but are distinguished from vertebrate BChE~T~s. Moreover, another hybrid dimer, between human AChE~BChE-T~ and chicken AChE~T~, which contained the similar FHB but different t-peptides, was formed when they were co-expressed together in HEK293T cultured cells (Chen et al., [@B10]). This further confirmed that the catalytic domains, possibly the FHB domains, should play a critical role in the selection of subunits during the dimerization of ChEs.

![**Comparison of FHB sequences of AChE~T~ and BChE~T~ among different species**. The sequences of the two alpha helices (FHB-1 and FHB-2) forming the dimeric contact zone of AChE and BChE are shown. The residues conserved across species are highlighted in bold. The amino acid sequences of human, mouse, rat, chicken, and *Torpedo* AChE catalytic subunits were deduced from nucleotide sequences accessed from GeneBank™ AAA68151, CAA39867, EDM13278, P36196, and CAA27169, respectively. The amino acid sequences of human, mouse, rat, and chicken BChE catalytic subunits were deduced from nucleotide sequences accessed from GeneBank™ AAA99296.1, AAH99977, NP_075231, and NP_989977, respectively.](fnmol-04-00036-g003){#F3}

According to our current knowledge, the oligomerization of AChE~T~ or BChE~T~ with their associated anchoring proteins could rely on three types of interactions (Figure [4](#F4){ref-type="fig"}): (i) the FHB interaction for the formation of dimer through hydrophobic interaction; (ii) intercatenary disulfide bonds between the t-peptide of AChE~T~ or BChE~T~ subunits; and (iii) tight hydrophobic interaction between the WAT domains of AChE~T~ or BChE~T~ subunits and the PRAD on PRiMA or ColQ.

![**Three types of interaction involved in the oligomerization of AChE and BChE**. **(A)** The FHB domains of AChE~T~ or BChE~T~ direct the dimer formation. **(B)** The t-peptides of AChE~T~ or BChE~T~ form intercatenary disulfide bonds. **(C)** WAT domains of AChE~T~ and BChE~T~ interact with PRAD on PRiMA or ColQ.](fnmol-04-00036-g004){#F4}

*N*-glycosylation is not required for the assembly of AChE~T~ but is required for the membrane trafficking
----------------------------------------------------------------------------------------------------------

AChE~T~ and BChE~T~ are well-known highly glycosylated enzymes, which carry various amounts of N-linked carbohydrate side chains attached to their core polypeptides (Liao et al., [@B37]; Kolarich et al., [@B27]). Mature human AChE~T~ monomer possesses three potential N-linked glycosylation sites (Soreq et al., [@B59]; Velan et al., [@B64]). Mature human BChE~T~ carries nine potential N-linked glycosylation sites (Lockridge et al., [@B38]). These N-linked glycosylation sites, both in AChE and BChE, are highly conserved in mammals, which implies the physiological importance of these glycans for ChEs.

Glycosylation is proposed to be used as a marker for the progression of ChE forms through different subcellular compartments, since it is known that the glycans added in ER are remodeled and matured in Golgi apparatus. In chicken muscles, the assembly of catalytically active dimer and tetramer occurred in the rough ER, with a subset of tetramers being further assembled with ColQ in Golgi apparatus into asymmetric forms (Rotundo, [@B51]). Once assembled, these catalytically active AChE oligomers were stable, acquired complex oligosaccharides in Golgi apparatus, and were transported to plasma membrane or secreted into medium (Rotundo, [@B51]). All of these exported AChE molecules contain complex oligosaccharides, because they could bind to lectins such as wheat germ agglutinin and ricin, and were endoglycosidase H (Endo H) resistant (Rotundo et al., [@B53]). In contrast, 70--80% of the newly synthesized AChE polypeptide chains in chicken muscle appeared to be catalytically inactive and Endo H sensitive, and they were degraded intracellularly with a half-life of about 1.5 h (Rotundo, [@B52]). Recently, Ruiz and Rotundo ([@B54],[@B55]) reported that the expression of AChE in quail muscles is regulated by muscle activity through post-translational controls: the over-expression of ER molecular chaperons, such as calnexin, ER protein 72, and protein disulfide isomerase results in an increase of catalytic active ColQ-linked AChE in quail muscles.

The biological function of the glycans on ChEs was elucidated by site mutagenesis studies. Elimination of *N*-glycosylation sites did not interfere with the ability of AChE~T~ to form a soluble dimer (Velan et al., [@B64]), or to assembly with PRiMA to form a PRiMA-linked AChE tetramer (Chen et al., [@B9]). It appears therefore that the oligosaccharide side chains do not affect the structural elements that are responsible for the interaction of different subunits. Indeed, none of the *N*-glycosylation sites on AChE is close to or within the FHB domain implied in dimerization of AChE subunits (Sussman et al., [@B61]; Morel et al., [@B45]), or the t-peptide that allows the oligomerization of AChE~T~ with the anchoring proteins, e.g., ColQ and PRiMA (Bon et al., [@B6]). Moreover, the glycosylation of AChE~T~ can greatly affects the protein folding and membrane trafficking. When the glycosylation is eliminated, the folding of AChE~T~ fails, leading to a severe lost of the enzymatic activity (Chen et al., [@B9]). In the absence of glycosylation, the secreted G~1~ and G~2~ AChE are dramatically reduced in transfected cells, and the PRiMA-linked G~4~ AChE is retained in ER and fails to be exported to plasma membrane (Chen et al., [@B9]).

The importance of *N*-glycosylation in the biosynthesis of AChE could explain the abnormality of glycosylation status in some pathological conditions. Proper glycosylation of AChE is important for normal brain function. Accumulation of molecular forms of AChE with altered patterns of glycosylation has been observed in the brain and cerebrospinal fluid of Alzheimer's patients (Sáez-Valero et al., [@B57], [@B56]). Moreover, characteristics of AChE found in the senile plaques are different from those in normal brain with a higher degree of glycosylation, which is proposed to be one of the factors facilitating formation of amyloid fibrils in the senile plaques (Mimori et al., [@B44]). These abnormalities in the glycosylation of AChE are very specific for Alzheimer's disease and are not detected in other dementia illness, which suggests that glycosylation of AChE may have a diagnostic value.

To summarize the assembly and membrane processing of G~4~ ChEs, a model is being proposed as Figure [5](#F5){ref-type="fig"}. After the mRNAs are translated into peptides, AChE~T~ and BChE~T~ polypeptides undergo initial glycosylation, presumably in a co-translation manner. Shortly after the synthesis, the glycosylated AChE~T~ and BChE~T~ are assembled into homodimers spontaneously. When these homodimers encounter PRiMA, they form PRiMA-linked G~4~ AChE, or G~4~ BChE, or AChE--BChE G~4~ hybrid in ER. Afterward, PRiMA targets these G~4~ complexes to Golgi apparatus where AChE~T~ and BChE~T~ subunits have further glycosylation. This trafficking allows the G~4~ enzymes to be fully functional and finally become anchored onto the plasma membrane. During the whole process, the proper glycosylation of AChE~T~ is the key point for the membrane targeting. Without glycosylation, AChE~T~ polypeptides cannot fold properly, resulting in inactive AChE molecules. These un-glycosylated and inactive AChE~T~ molecules can still form PRiMA-linked G~4~ AChE and AChE--BChE G~4~ hybrid, but both of them are retained in ER, failing to be exported to Golgi apparatus, and finally they are subjected to degradation most possibly.

![**Proposed model for the assembly and membrane processing of G~4~ ChEs**. G~4~ AChE, G~4~ BChE, and AChE--BChE G~4~ hybrid molecules are assembled in ER where both AChE~T~ and BChE~T~ subunits have initial glycosylation. These G~4~ complexes are subsequently transported to Golgi apparatus where the catalytic subunits can have further glycosylation, and finally anchored onto the plasma membrane. The AChE~T~ glycosylation mutant, in which the glycosylation is completely abolished, is still able to assembly with PRiMA and BChE~T~ to form G~4~ AChE and G~4~ hybrid. However, both of them are retained in ER, which possibly will be subjected to the degradation pathway.](fnmol-04-00036-g005){#F5}

Summary
=======

The assembly of ChEs constitutes a fascinating model to study numerous biological processes, such as post-translational modification, protein--protein interactions, membrane trafficking, and protein degradation. The physiological function of ChEs depends on the catalytic property of the enzymes and the restricted subcellular localization. In brain and muscles, ChEs display extremely rich molecular polymorphisms, possessing soluble, membrane-bound and basal lamina-anchored forms, and additionally, hybrid ChEs containing both AChE and BChE catalytic subunits also curiously exist. During the assembly of these ChE complexes, dimer is believed to be the precursor for the PRiMA-linked tetramers and ColQ-linked asymmetric forms. The dimer formation of AChE or BChE depends on recognition between the FHB domains in their catalytic domains, and the assembly of tetramers with PRiMA or ColQ requires the interaction of WAT domain on the C-terminal t-peptides with the PRAD domain on PRiMA or ColQ. N-linked glycans of AChE are employed as both maturation and quality control tags that dictate the destination of the enzyme being exported or not, which inspires that the control of glycosylation may be as a means in regulating the level of functional AChE in pathological conditions. However, there are still several questions out there, which have not been resolved. These questions are: (i) the possible control mechanism in directing the formation of different forms of ChEs; (ii) the regulatory mechanism for the protein trafficking of different states of ChEs; (iii) the fate of the active and inactive ChEs; and (iv) the possible non-cholinergic function of different forms of ChEs.
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